ConductScience.org, home

Paper23764751

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.

Zhang B and 11 others. Br J Cancer, 2013. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. Papers, record 23764751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23764751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
PubMed
Journal
Br J Cancer
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
2.19
iCite
Revised in PubMed
2022-03-21
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang BB
2Dong LWL-W
3Tan YXY-X
4Zhang JJ
5Pan YFY-F
6Yang CC
7Li MHM-H
8Ding ZWZ-W
9Liu LJL-J
10Jiang TYT-Y
11Yang JHJ-H
12Wang HYH-Y

Source PubMed

Download CSV of authors

Topics28

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aspartate-Ammonia LigaseMajor topic
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Adult
Animals
Asparaginase
Biomarkers, Tumor
Cell Line, Tumor
Cell Movement
Cell Proliferation
Drug Resistance, Neoplasm
Female
Gene Expression
Humans
Male
Mice
Mice, Nude
Middle Aged
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Staging
Prognosis
RNA Interference
RNA, Small Interfering
Survival
Tissue Array Analysis
Xenograft Model Antitumor Assays
alpha-Fetoproteins

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121654208Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma.Autophagy2011https://conductscience.org/library/papers/21654208PubMed
214632770In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.Br J Haematol2003https://conductscience.org/library/papers/14632770PubMed
315970674TELAML1-positive ALL: a discordant genotype.Cell Cycle2005https://conductscience.org/library/papers/15970674PubMed
412433682Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.Blood2003https://conductscience.org/library/papers/12433682PubMed
520496989
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Leuk Lymphoma2010https://conductscience.org/library/papers/20496989PubMed
617088436Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.Mol Cancer Ther2006https://conductscience.org/library/papers/17088436PubMed
721351269Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.Int J Cancer2010https://conductscience.org/library/papers/21351269PubMed
811415466Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.Biochem J2001https://conductscience.org/library/papers/11415466PubMed
917409444Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin.Cancer Res2007https://conductscience.org/library/papers/17409444PubMed
101972978A mammalian temperature-sensitive mutation affecting G1 progression results from a single amino acid substitution in asparagine synthetase.Nucleic Acids Res1990https://conductscience.org/library/papers/1972978PubMed
1111939270Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.Int J Hematol2002https://conductscience.org/library/papers/11939270PubMed
123470743Molecular cloning of a gene that is necessary for G1 progression in mammalian cells.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3470743PubMed
1310086723
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.
Leukemia1999https://conductscience.org/library/papers/10086723PubMed
1416156856Selective apoptosis of natural killer-cell tumours by l-asparaginase.Br J Haematol2005https://conductscience.org/library/papers/16156856PubMed
1517380207Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.J Clin Invest2007https://conductscience.org/library/papers/17380207PubMed
1615385533
Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation.
J Biol Chem2004https://conductscience.org/library/papers/15385533PubMed
1712097650Genomic sequences necessary for transcriptional activation by amino acid deprivation of mammalian cells.J Nutr2002https://conductscience.org/library/papers/12097650PubMed
1821702992Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.BMC Cancer2011https://conductscience.org/library/papers/21702992PubMed
1915718422Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.Blood2005https://conductscience.org/library/papers/15718422PubMed
2012196214Childhood acute lymphoblastic leukemia.Rev Clin Exp Hematol2002https://conductscience.org/library/papers/12196214PubMed

See all 34 referencesDownload CSV of references

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42286241PKPD-Based Translational Modeling of Calaspargase Pegol Preclinical Activity in Hepatocellular Carcinoma.Eur J Drug Metab Pharmacokinet2026https://conductscience.org/library/papers/42286241PubMed
42219486SomaScan proteomics reveals novel biomarkers in the progression of liver cirrhosis to hepatocellular carcinoma.BMC Med Genomics2026https://conductscience.org/library/papers/42219486PubMed
41806079Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities.Mol Biomed2026https://conductscience.org/library/papers/41806079PubMed
41463097Asparagine synthetase (ASNS) Drives Tumorigenicity in Small Cell Lung Cancer.Biomedicines2025https://conductscience.org/library/papers/41463097PubMed
41179661Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects.Front Oncol2025https://conductscience.org/library/papers/41179661PubMed
41154605Unveiling Metabolic Signatures as Potential Biomarkers in Common Cancers: Insights from Lung, Breast, Colorectal, Liver, and Gastric Tumours.Biomolecules2025https://conductscience.org/library/papers/41154605PubMed
41074146Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma.Biomark Res2025https://conductscience.org/library/papers/41074146PubMed
40416363Targeting the Exonic Circular OGT RNA/O-GlcNAc Transferase/Forkhead Box C1 Axis Inhibits Asparagine- and Alanine-Mediated Ferroptosis Repression in Neuroblastoma Progression.Research (Wash D C)2025https://conductscience.org/library/papers/40416363PubMed
40025169Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications.Exp Mol Med2025https://conductscience.org/library/papers/40025169PubMed
39796613Targeting Asparagine Metabolism in Solid Tumors.Nutrients2025https://conductscience.org/library/papers/39796613PubMed
39378065CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.Future Oncol2024https://conductscience.org/library/papers/39378065PubMed
39006147Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.Hepatol Forum2024https://conductscience.org/library/papers/39006147PubMed
38959335Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer.Cancer Res2024https://conductscience.org/library/papers/38959335PubMed
38739260The Role of Phthalocyanine-Gold Nanoconjugates (Pc-Au NCs) in Ameliorating the Hepatic and Renal Toxicity-Induced by Silver Nanoparticles (Ag NPs) in Male Rats.Biol Trace Elem Res2024https://conductscience.org/library/papers/38739260PubMed
38370444Modifications of the GH Axis Reveal Unique Sexually Dimorphic Liver Signatures for Lcn13, Asns, Hamp2, Hao2, and Pgc1a.J Endocr Soc2024https://conductscience.org/library/papers/38370444PubMed
37664666Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of asparagine synthetase.Oncol Lett2023https://conductscience.org/library/papers/37664666PubMed
37108625Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses.Int J Mol Sci2023https://conductscience.org/library/papers/37108625PubMed
36980965Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype.Genes (Basel)2023https://conductscience.org/library/papers/36980965PubMed
36914921Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem.Mikrochim Acta2023https://conductscience.org/library/papers/36914921PubMed
36618350Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.Front Immunol2022https://conductscience.org/library/papers/36618350PubMed

See all 60 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene
ASNS440PubTator's text mininghttps://conductscience.org/library/genes/440NCBI Gene
ASPG374569PubTator's text mininghttps://conductscience.org/library/genes/374569NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23764751

GET https://conductscience.org/api/papers/v1/23764751/references?page=2